Burkett Financial Services »

Alnylam Pharmaceuticals shares owned by Burkett Financial Services

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Burkett Financial Services from 13F filings

Historical chart of Burkett Financial Services investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Burkett Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Burkett Financial Services

Quarter filed Position value Share count Share price at filing
2026-09-30 $37k 149 246.74

More positions owned by Burkett Financial Services

Schwab US Large Cap Growth ETF Equity (SCHG)
Schwab US Dividend Equity ETF Equity (SCHD)
MSCI EAFE Hedged Dollar ETF Equity (DBEF)
Vanguard FTSE Developed Markets ETF Equity (VEA)
Eagle Capital Select Equity ETF Equity (EAGL)
JP Morgan Active Emerging Market Equity (JEMA)
Calamos S&P Structured ALT ETF Equity (CPSL)
iShares S&P 400 Mid Index Equity (IJH)
iShares S&P 600 Small Cap Index Equity (IJR)
Loar Holdings Equity (LOAR)
Apple Equity (AAPL)
Microsoft Corp Equity (MSFT)
Vanguard Intermediate Treasury ETF Equity (VGIT)
Schwab Mid Cap Blend ETF Equity (SCHM)
iShares S&P 500 Growth Equity (IVW)

View all positions for Burkett Financial Services

Top funds holding Alnylam Pharmaceuticals

FMR
BlackRock
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
Invesco
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Wellington Management Company
Orbis Allan Gray
Dodge & Cox
Two Sigma Investments

View all funds holding Alnylam Pharmaceuticals